Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Friday, March 29, 2024 · 699,672,445 Articles · 3+ Million Readers

Green Spirit Requested Final Inspection of Third Medicinal Cannabis Dispensary in Puerto Rico

New Green Spirit RX Dispensary in Hato Rey Neighborhood of San Juan Awaits Final Inspection and Issuance of Occupational License for Establishment

DORADO, Puerto Rico, May 17, 2018 (GLOBE NEWSWIRE) -- Green Spirit Industries Inc. (OTC Pink:GSRX) (“Green Spirit” or, the “Company”) announced today that it has requested final inspection of its medicinal cannabis dispensary located in the Hato Rey neighborhood of San Juan, Puerto Rico by the Department of Health of Puerto Rico (the “DHPR”). The Company previously announced (Construction Completed at Hato Rey Dispensary) completion of construction of its third medical cannabis dispensary located in Hato Rey. The Company is now in the process of staffing the location, and once the dispensary passes inspection and the DHPR issues the requisite Occupational License for Establishment, the Company will be ready to begin operations. 

Green Spirit’s newest dispensary is located at Calle César González #508, Hato Rey, Puerto Rico 00918, a heavily trafficked area that is in close proximity to a large concentration of medical facilities, most notably Clinica las Americas Medical Center and El Maestro Hospital. San Juan’s Hato Rey district includes a mix of both residential and commercial properties and is the city’s most densely populated district. 

The Company anticipates completing construction at other locations during the second quarter of 2018, with operations commencing thereafter upon receipt of the requisite operating permits from the DHPR. For more information about Green Spirit, visit the Company’s website at http://www.greenspiritrx.com/.

About Green Spirit Industries Inc.
Green Spirit Industries Inc. (OTC Pink:GSRX), through its subsidiaries, is in the business of acquiring, developing and operating retail cannabis dispensaries, and is in the process of expanding its business to include the cultivation, extraction, manufacture and delivery of cannabis and cannabinoid products.

Forward-Looking Statements
This press release contains forward-looking statements. Such statements include statements regarding our expectations, hopes, beliefs or intentions regarding the future, including but not limited to statements regarding our market, strategy, competition, development plans (including acquisitions and expansion), financing, revenues, operations, and compliance with applicable laws. Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in any such statement. Factors that could cause actual results to differ materially from such forward-looking statements include the risks described in greater detail in the following paragraphs. All forward-looking statements in this document are made as of the date hereof, based on information available to us as of the date hereof, and we assume no obligation to update any forward-looking statement except where applicable law requires us to update these statements. Market data used throughout this prospectus is based on published third party reports or the good faith estimates of management, which estimates are based upon their review of internal surveys, independent industry publications and other publicly available information.

Contact:
Paul Gendreau
PGPR
paul@pgprmedia.com
678-807-7945

Powered by EIN News


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release